TBPH Earnings

Quarterly EPS
$-0.34
Q2 2024
$-0.26
Q3 2024
$-0.31
Q4 2024
$-0.27
Q1 2025
$1.09
Q2 2025
$0.07
Q3 2025
$1.20
Q4 2025
$-0.10
Q1 2026
Latest Revenue17.7M
Latest Net Income-4933000
EPS & Revenue Trend
PeriodEPSRevenueNet IncomeRev YoYEPS YoY
Q1 2026-$0.1017.7M-4933000+15.0%+63.0%
Q4 2025$1.2045.9M61.0M+144.7%+487.1%
Q3 2025$0.0720.0M3.6M+18.5%+126.9%
Q2 2025$1.0926.2M54.8M+83.7%+420.6%
Q1 2025-$0.2715.4M-13579000+6.1%-12.5%
Q4 2024-$0.3118.8M-15527000+6.8%-82.4%
Q3 2024-$0.2616.9M-12698000+7.5%-52.9%
Q2 2024-$0.3414.3M-16510000+3.7%-21.4%
Q1 2024-$0.2414.5M-11664000
Q4 2023-$0.1717.6M-8510000
Q3 2023-$0.1715.7M-8950000
Q2 2023-$0.2813.7M-15645000
Theravance Biopharma (TBPH) — Earnings